glp 1 sema FDA Approves Oral Semaglutide: First GLP-1 Weight Loss Pill SEMA (GLP-1) 10mg

The authors of this article stated their research indicated that elderly subjects who were supplementing nutritionally were shown to have a more robust response to vaccinations (1)

Saudi J Biol Sci 28:49874993

Injectable GLP-1 therapies have faced persistent challenges in real-world settings, including supply shortages, high monthly costs, and discontinuation rates linked to side effects and needle aversion

Chaudhuri, A

1 C, E ) but not amplitude, consistent with it being a presynaptic precursor of glutamate

Those on blood thinners should be aware that any injection carries bleeding risk and should use appropriate caution